Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Detecting vulnerable plaque using peripheral blood: inflammatory and cellular markers.

Robert S Schwartz1, Antonio Bayes-Genis, John R Lesser

  • 1Minnesota Cardiovascular Research Institute, Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA. rss@rsschwartz.com

Journal of Interventional Cardiology
|June 13, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The longevity effects of reduced IGF-1 signaling depend on the stability of the mitochondrial genome.

Science advances·2026
Same author

Access to medical care globally for patients with peripartum cardiomyopathy: a clinical consensus statement of the Heart Failure Association of the ESC.

European journal of heart failure·2026
Same author

A Clinical Risk Prediction Model for Identifying Patient Candidates for Same-day Discharge After Transcatheter Aortic Valve Replacement.

Journal of the Society for Cardiovascular Angiography & Interventions·2026
Same author

Pharmacologic pitfalls in heart failure: A guide to drugs that may cause or exacerbate heart failure. A European Journal of Heart Failure expert consensus document.

European journal of heart failure·2025
Same author

Quantitative rest and stress perfusion in acute and recovery takotsubo syndrome-new physiological insights from cardiac magnetic resonance.

European heart journal. Cardiovascular Imaging·2025
Same author

The longevity effects of reduced IGF-1 signaling depend on the stability of the mitochondrial genome.

bioRxiv : the preprint server for biology·2025

High-sensitivity C-reactive protein (hs-CRP) is a key marker for arterial inflammation and future cardiovascular events. Measuring hs-CRP, along with other inflammatory markers, improves risk assessment for vulnerable patients.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Inflammation Research

Background:

  • Coronary atherosclerosis presents as two distinct syndromes: stable and unstable.
  • Unstable acute coronary syndromes stem from vascular inflammatory processes, distinct from stable syndromes caused by fixed stenoses.
  • Identifying vulnerable patients and plaques remains a diagnostic challenge due to low prevalence and current test limitations.

Purpose of the Study:

  • To highlight the role of inflammatory markers in identifying patients at risk for cardiovascular events.
  • To underscore the diagnostic challenges in detecting vulnerable plaques.
  • To emphasize the need for improved risk assessment strategies in cardiology.

Main Methods:

  • Review of current understanding of coronary atherosclerosis pathophysiology.

Related Experiment Videos

  • Analysis of the correlative strength of high-sensitivity C-reactive protein (hs-CRP) for clinical events.
  • Evaluation of hs-CRP, IL-6, and ICAM-1 in conjunction with lipid levels for risk assessment.

    • Main Results:

    • hs-CRP is the strongest correlative factor for future clinical events related to arterial inflammation.
    • CRP plasma levels provide the best risk assessment in various cardiac conditions, including stable/unstable angina and post-myocardial infarction.
    • Combining CRP, IL-6, and ICAM-1 with lipid levels significantly improves cardiovascular risk assessment over lipids alone.

    Conclusions:

    • hs-CRP is a crucial biomarker for arterial inflammation and predicting cardiovascular events.
    • Enhanced risk assessment can be achieved by incorporating inflammatory markers into diagnostic panels.
    • Further development of sensitive and specific risk marker panels is essential for accurately identifying vulnerable plaques.